Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving 500+ biopharmaceutical companies globally:

Harvard Business School
Merck
Farmers Insurance
Chubb
Express Scripts
Baxter
Mallinckrodt
Novartis
Healthtrust
Julphar

Generated: August 22, 2017

DrugPatentWatch Database Preview

PROSOM Drug Profile

« Back to Dashboard

Which patents cover Prosom, and when can generic versions of Prosom launch?

Prosom is a drug marketed by Abbott and is included in one NDA.

The generic ingredient in PROSOM is estazolam. There are three drug master file entries for this compound. Five suppliers are listed for this compound. Additional details are available on the estazolam profile page.

Summary for Tradename: PROSOM

Patents:0
Applicants:1
NDAs:1
Bulk Api Vendors: see list28
Patent Applications: see list2,314
Formulation / Manufacturing:see details
Drug Prices:see details
DailyMed Link:PROSOM at DailyMed
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Abbott
PROSOM
estazolam
TABLET;ORAL019080-001Dec 26, 1990DISCNYesNo► Subscribe► Subscribe► Subscribe
Abbott
PROSOM
estazolam
TABLET;ORAL019080-002Dec 26, 1990DISCNYesNo► Subscribe► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Expired Patents for Tradename: PROSOM

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Abbott
PROSOM
estazolam
TABLET;ORAL019080-001Dec 26, 1990► Subscribe► Subscribe
Abbott
PROSOM
estazolam
TABLET;ORAL019080-002Dec 26, 1990► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving 500+ biopharmaceutical companies globally:

Cantor Fitzgerald
Accenture
Express Scripts
Novartis
Boehringer Ingelheim
Dow
Chinese Patent Office
Cerilliant
Mallinckrodt
Colorcon

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted Heap | Mobile and Web Analytics
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot